Skip to main content
Premium Trial:

Request an Annual Quote

DNAnexus, Saphetor Integrating Technologies for NGS Interpretation

CHICAGO (GenomeWeb) – Genome informatics vendor DNAnexus and variant analysis software company Saphetor are integrating their technologies in hopes of creating a seamless platform for genome-based biomarker discovery and interpretation.

Users can now access Saphetor's technology to annotate and classify variants from next-generation sequencing directly from the DNAnexus cloud platform, the two companies said. Saphetor performs whole-genome analysis by running NGS results through a database of 33 billion variant annotation points.

"Together with the scalability and high-performance computing power of the DNAnexus platform, and Saphetor’s variant browsing tools, customers can quickly move from NGS data analysis to interpretation," DNAnexus scientist Chai Fungtammasan wrote in a blog post. "Researchers can discover which variants have a functional impact on disease in the hopes of accelerating the implementation of precision medicine."

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.